Coronavirus: the latest Israeli data shows that vaccines work – 0.1% infected

Coronavirus: the latest Israeli data shows that vaccines work – 0.1% infected

by
Less than 0.1% of individuals who received the second dose of the Pfizer vaccine contracted the disease, according to data released Thursday night by Maccabi Healthcare Services.
The vaccine’s effectiveness in Israel is now 93%, according to the data. The Pfizer vaccine proved to be 95% effective in its Phase III clinical trials.

The report showed that, from the data tracked until February 11, when a week has passed since 523,000 people received their second injection, only 544 people were infected.

“The data prove unequivocally that the vaccine is very effective and we have no doubt that it saved the lives of many Israelis,” said Dr. Miri Mizrahi Reuveni, head of the Maccabi health division.

No one who was vaccinated died. In addition, most of those who contracted the virus had only mild symptoms or no symptoms at all.

“Out of 544 infected, only 15 people needed hospitalization,” said the report, “four of which were defined as severely ill, three as moderate and eight as mild.”

Maccabi did a random test among its unvaccinated customers at the same time and found that out of 628,000 members of different profiles, 18,425 contracted coronavirus during the same period – 2.9%.

“As there is active morbidity among children and adolescents up to 16 years of age who cannot be vaccinated and mutations of the virus are much more contagious, this means that those who do not get vaccinated will be infected sooner or later,” Mizrahi Reuveni argued. “Please hurry up and make an appointment as soon as possible. Protect yourself from a serious illness and, God forbid, death, as well as the possibility of infecting and putting other people in danger. “

So far, Maccabi has vaccinated more than a million members with at least one dose of the Pfizer vaccine against the coronavirus. The country inoculated more than 3.7 million, including about 2.4 million with its second injection.

On Thursday, Eran Segal, a computational biologist at the Weizmann Institute of Science, reported that since the peak of morbidity in mid-January, there has been a 38% reduction in the number of critically ill patients and a 40% reduction in the number of deaths in the population over 60 years.

He also said that there are 58% fewer new older patients and 44% fewer hospitalizations in general.

“About three weeks ago, they started receiving the second dose of the vaccine,” wrote Segal.

Source